Eikon Therapeutics alternatives and competitors
The closest alternatives to Eikon Therapeutics are Recursion, Verge Labs, insitro and Earendil Labs.
Drug discovery company built around super resolution live cell fluorescence microscopy, applying advanced optics descended from Nobel recognized single molecule imaging work together with machine learning to track how individual proteins behave and move inside living cells, rather than…
10 alternatives to Eikon Therapeutics
What each product does, with its price as the vendor publishes it.
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
V
Clinical stage biotechnology company now trading as Verge Labs, applying machine learning to human tissue derived multiomic data in neurology.
-
I
insitro is a South San Francisco AI therapeutics company founded in 2018 by Daphne Koller, built on causal biology.
Price: Not applicable
-
E
Earendil Labs uses AI to design antibody drugs and develops them through its own pipeline, licensing individual programs to large pharmaceutical companies.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
R
Clinical stage precision medicine company in Cambridge, Massachusetts (Nasdaq: RLAY), built around the Dynamo platform and an approach it calls motion based drug design: proteins move, binding sites appear only in particular conformational states, and a discovery method anchored to static…
Price: Not applicable
-
C
Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target.
Price: Not applicable
-
X
South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs.
Price: Not applicable
-
N
Noetik builds AI models of how tumors behave and licenses them to drug companies for cancer research. The models help researchers find targets, run virtual experiments and predict which patients will respond to a therapy.
Price: No published price
-
I
Immunai occupies a different position from most of this category. It is not developing its own drugs.
Price: No published price
Eikon Therapeutics alternatives, answered
What are the best alternatives to Eikon Therapeutics?
The closest alternatives to Eikon Therapeutics are Recursion, Verge Labs, insitro, Earendil Labs and Superluminal Medicines. Clinical stage biotechnology company now trading as Verge Labs, applying machine learning to human tissue derived multiomic data in neurology. insitro is a South San Francisco AI therapeutics company founded in 2018 by Daphne Koller, built on causal biology. Earendil Labs uses AI to design antibody drugs and develops them through its own pipeline, licensing individual programs to large pharmaceutical companies.
Who are Eikon Therapeutics's competitors?
Eikon Therapeutics's competitors in the Drug Discovery AI category include Recursion, Verge Labs, insitro, Earendil Labs, Superluminal Medicines and Relay Therapeutics.